{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:54:32Z","timestamp":1778356472934,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004776","name":"Faculty of Medicine, Chulalongkorn University","doi-asserted-by":"publisher","award":["RA 35\/53"],"award-info":[{"award-number":["RA 35\/53"]}],"id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virus Eradication"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jve.2020.100005","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T10:33:49Z","timestamp":1595154829000},"page":"100005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count &lt;200\u00a0\u200bcells\/mm3 in Thailand"],"prefix":"10.1016","volume":"6","author":[{"given":"Win Min","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasiwimol","family":"Ubolyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanakorn","family":"Apornpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pokrath","family":"Hansasuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivaporn","family":"Gatechompol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wirach","family":"Maekanantawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praphan","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintanat","family":"Ananworanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol. Rev."},{"issue":"4657","key":"10.1016\/j.jve.2020.100005_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1126\/science.6328660","article-title":"Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes","volume":"225","author":"Klatzmann","year":"1984","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7326\/0003-4819-111-3-223","article-title":"CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection","volume":"111","author":"Masur","year":"1989","journal-title":"Ann. Intern. Med."},{"issue":"9672","key":"10.1016\/j.jve.2020.100005_bib4","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"When To Start","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jve.2020.100005_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jve.2020.100005_bib6","series-title":"Guideline on when to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV","author":"WHO","year":"2015"},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.COH.0000194106.12816.b1","article-title":"The CD4 lymphocyte count and risk of clinical progression","volume":"1","author":"Phillips","year":"2006","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"14","key":"10.1016\/j.jve.2020.100005_bib8","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/00002030-200109280-00002","article-title":"Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function","volume":"15","author":"Teixeira","year":"2001","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.jve.2020.100005_bib9","first-page":"88","article-title":"Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART","volume":"8","author":"Aiuti","year":"2006","journal-title":"AIDS Rev."},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/QAI.0b013e318042e1c3","article-title":"Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration","volume":"45","author":"Tuboi","year":"2007","journal-title":"J.\u00a0Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1468-1293.2003.00156.x","article-title":"Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study","volume":"4","author":"Florence","year":"2003","journal-title":"HIV Med."},{"key":"10.1016\/j.jve.2020.100005_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-6405-5-23","article-title":"Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance","volume":"5","author":"Nakanjako","year":"2008","journal-title":"AIDS Res. Ther."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/431484","article-title":"Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells\/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jve.2020.100005_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/cid\/cir898","article-title":"AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d\u2019Ivoire","volume":"54","author":"Anglaret","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib15","article-title":"CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE","volume":"9","author":"Young","year":"2012","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/695852","article-title":"The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options","volume":"48","author":"d\u2019Arminio Monforte","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jve.2020.100005_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/QAI.0b013e31817bebb3","article-title":"Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases","volume":"48","author":"Baker","year":"2008","journal-title":"J.\u00a0Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jve.2020.100005_bib18","doi-asserted-by":"crossref","first-page":"670957","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions","volume":"2012","author":"Gaardbo","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jve.2020.100005_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2334-12-293","article-title":"Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study","volume":"12","author":"Thorsteinsson","year":"2012","journal-title":"BMC Infect. Dis."},{"issue":"22","key":"10.1016\/j.jve.2020.100005_bib20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jve.2020.100005_bib21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"issue":"21","key":"10.1016\/j.jve.2020.100005_bib22","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.75.21.10319-10325.2001","article-title":"Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals","volume":"75","author":"Llano","year":"2001","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12981-018-0200-4","article-title":"CD4\/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV","volume":"15","author":"Han","year":"2018","journal-title":"AIDS Res. Ther."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib24","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","article-title":"CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study","volume":"2","author":"Mussini","year":"2015","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.jve.2020.100005_bib25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"Giorgi","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jve.2020.100005_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2334-11-43","article-title":"High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort","volume":"11","author":"Nakanjako","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/aid.2015.0058","article-title":"Late presentation into care of HIV disease and its associated factors in Asia: results of TAHOD","volume":"32","author":"Jeong","year":"2016","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"6","key":"10.1016\/j.jve.2020.100005_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179870","article-title":"Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up","volume":"12","author":"Lin","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3851\/IMP2673","article-title":"Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy","volume":"19","author":"Avihingsanon","year":"2014","journal-title":"Antivir. Ther."},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/cit173","article-title":"Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality","volume":"57","author":"Durier","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jve.2020.100005_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2334-6-59","article-title":"CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa","volume":"6","author":"Lawn","year":"2006","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/431484","article-title":"Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells\/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jve.2020.100005_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1468-1293.2008.00564.x","article-title":"Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study","volume":"9","author":"Omland","year":"2008","journal-title":"HIV Med."},{"issue":"4","key":"10.1016\/j.jve.2020.100005_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/655152","article-title":"CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection","volume":"51","author":"Maggiolo","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jve.2020.100005_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/QAD.0000000000001801","article-title":"Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa","volume":"32","author":"Kroeze","year":"2018","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/510746","article-title":"CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression","volume":"44","author":"Moore","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jve.2020.100005_bib37","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/QAD.0b013e32833adbcf","article-title":"Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection","volume":"24","author":"Lok","year":"2010","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ije\/dyu271","article-title":"CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa","volume":"44","author":"Geng","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.jve.2020.100005_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/hiv.12567","article-title":"Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion","volume":"19","author":"Stirrup","year":"2018","journal-title":"HIV Med."},{"issue":"10","key":"10.1016\/j.jve.2020.100005_bib40","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI5863","article-title":"Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues","volume":"103","author":"Bucy","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"issue":"17","key":"10.1016\/j.jve.2020.100005_bib41","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1097\/QAD.0000000000000805","article-title":"Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?","volume":"29","author":"Jarrin","year":"2015","journal-title":"Aids"},{"issue":"8","key":"10.1016\/j.jve.2020.100005_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/00002030-200305230-00005","article-title":"T\u00a0cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment","volume":"17","author":"Diaz","year":"2003","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/hiv.12081","article-title":"The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery","volume":"15","author":"Serrano-Villar","year":"2014","journal-title":"HIV Med."},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12981-018-0200-4","article-title":"CD4\/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV","volume":"15","author":"Han","year":"2018","journal-title":"AIDS Res. Ther."},{"issue":"9","key":"10.1016\/j.jve.2020.100005_bib45","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/651689","article-title":"Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications","volume":"50","author":"Negredo","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jve.2020.100005_bib46","first-page":"43","article-title":"Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection","volume":"2","author":"Ananworanich","year":"2016","journal-title":"J.\u00a0Virus. Erad."}],"container-title":["Journal of Virus Eradication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664020311547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664020311547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:10:47Z","timestamp":1761855047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2055664020311547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2055664020311547"],"URL":"https:\/\/doi.org\/10.1016\/j.jve.2020.100005","relation":{},"ISSN":["2055-6640"],"issn-type":[{"value":"2055-6640","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200\u00a0\u200bcells\/mm3 in Thailand","name":"articletitle","label":"Article Title"},{"value":"Journal of Virus Eradication","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jve.2020.100005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100005"}}